ArticleCancer medicine2025

Plasma-Based Genomic Features Influencing Outcomes of T790M-Positive Non-Small Cell Lung Cancer Receiving Osimertinib.

Heng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.